Postoperative Patient with Suspected Bleeding
Signs: Tachycardia (earliest sign), hypotension, dropping Hb, increasing drain output (bloody), wound hematoma, altered mental status, oliguria, cool extremities.
Postoperative Hemorrhage Management: Postoperative Patient with Suspected Bleeding → Rapid Assessment → Hemodynamic Status? → ⚠️ Don't Wait for Labs.
Pathway Overview
15 steps
15 total
Signs: Tachycardia (earliest sign), hypotension, dropping Hb, increasing drain output (bloody), wound hematoma, altered mental status, oliguria, cool extremities.
1) ABC assessment - ensure airway/breathing stable. 2) Two large-bore IVs (if not present). 3) Type & Screen (crossmatch if not done). 4) STAT labs: CBC, coags (PT/INR/PTT/fibrinogen), lactate, BMP. 5) Check drain output, wound, surgical site. 6) Review operative report for bleeding risks.
STABLE: SBP >90, MAP >65, HR <120, mentating, adequate UOP. UNSTABLE: Hypotension, tachycardia >120, altered mental status, poor perfusion, oliguria. SHOCK: SBP <80 or requiring vasopressors, unresponsive to initial fluids.
In active hemorrhage, don't wait for lab results to initiate transfusion. Clinical signs are more important than Hb level. By the time Hb drops significantly, patient may be in late decompensated shock. Treat the patient, not the lab.
1) Serial H&H q4-6h. 2) Coagulation profile. 3) Consider CT angiogram if source unclear. 4) Ultrasound for hematoma assessment. 5) Hold anticoagulation. 6) Type & Crossmatch 4 units pRBC.
Assess: Hb trend over 4-6 hours. Drain output rate. Transfusion requirement. SLOW: Hb stable or slow drop, drain output slowing. ONGOING: Continuous Hb drop, persistent high drain output, requiring repeated transfusion.
Bleeding appears self-limited. Serial Hb monitoring q6-8h. Transfuse for Hb <7 (or <8 if CAD). Correct coagulopathy. May resume prophylactic anticoagulation when stable. Continue monitoring for 24-48h.
1) ICU monitoring. 2) Serial labs to confirm stability. 3) Continue warming, correct electrolytes. 4) Mechanical VTE prophylaxis (hold anticoag until cleared by surgery). 5) Address anemia - may need further transfusion. 6) Debrief and document.
Hemostasis achieved. Vitals stable. Continue postoperative recovery. Plan for DVT prophylaxis resumption.
FFP for INR >1.5. Platelets for Plt <50K. Cryoprecipitate for fibrinogen <150. Vitamin K 10mg IV if warfarin. Prothrombin complex concentrate (PCC) for warfarin/factor Xa inhibitors. Idarucizumab for dabigatran. DDAVP for uremic bleeding or platelet dysfunction.
SURGICAL: Obvious wound bleeding, increasing drain output, hematoma. Often requires return to OR. COAGULOPATHIC: Oozing from all sites, no discrete source. Correct coagulopathy. MIXED: Common - both surgical bleeding and coagulopathy from blood loss.
YES if: Hemodynamic instability despite resuscitation, ongoing transfusion requirement (>4-6 units), expanding hematoma threatening airway/compartment, clear surgical source, failure to respond to correction of coagulopathy. NO if: Bleeding controlled with correction of coagulopathy, stable vital signs, self-limited bleeding.
1) Notify OR team - emergency case. 2) Continue resuscitation during transport. 3) Keep blood products infusing. 4) Intraoperative: Evacuate hematoma, identify source, achieve hemostasis. 5) Consider damage control if coagulopathic (pack, plan return). 6) ICU admission postop.
Consider angioembolization if: Discrete arterial source on CTA, patient stable enough for angio suite, suitable anatomy (hepatic, splenic, pelvic bleeding), IR available. Less invasive than reop for select cases. Not for rapid exsanguination.
1) Activate MTP (Massive Transfusion Protocol) if anticipated >10 units/24h. 2) Transfuse pRBC empirically (don't wait for labs). 3) Replace 1:1:1 ratio (pRBC:FFP:platelets). 4) Consider TXA (1g IV then 1g over 8h). 5) Calcium replacement (for citrate toxicity). 6) Keep patient warm.
Contemporary Surgical Practice - Postoperative Hemorrhage Management
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Applicable Regions
Global: Principles apply broadly; transfusion thresholds may vary
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Venous thromboembolism risk assessment for surgical patients
Compare
See how this pathway workflow compares against BMJ Best Practice.
Commercial
Run the pathway in a live AttendMe account with citations and tracked usage.
The Postoperative Hemorrhage Management is a emergency clinical algorithm for General Surgery. It provides a structured decision tree to guide clinical decision-making, based on Contemporary Surgical Practice - Postoperative Hemorrhage Management.
This algorithm is based on Contemporary Surgical Practice - Postoperative Hemorrhage Management (DOI: N/A - Consensus Practice).
Known limitations include: Thresholds may vary by procedure type; Anticoagulated patients require specific reversal protocols; IR availability varies by institution; Decision to return to OR requires clinical judgment; Does not address procedure-specific bleeding sources in detail. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the Postoperative Hemorrhage Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free